-
Feb 28, 2023, 09:34 AM
by
Kalderos Introduces New Product Suite to Better Serve Manufacturers Navigating Drug Discount Programs
Full story
-
Feb 28, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Oxford Nanopore Technologies and the Tecan Group announced their collaboration on an automated NGS library preparation workflow, and released a technical note outlining a proof-of-concept use case where the Oxford Nanopore’s Ligation Sequencing Kit XL V14 processing multiple DNA samples on the Tecan DreamPrep NGS achieves high yield and raw read sequencing modal accuracy of Q20 (99%) and above.
Full story
-
Feb 27, 2023, 10:22 AM
by
Full story
-
Feb 27, 2023, 10:21 AM
by
Full story
-
Feb 27, 2023, 10:21 AM
by
Full story
-
Feb 27, 2023, 10:16 AM
by
Full story
-
Feb 23, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Advanced machine learning provides objective tumor response assessments and unlocks novel biomarkers to predict patient outcomes; a comprehensive single-cell multi-omic solution enables the simultaneous exploration of the whole genome and whole mRNA transcriptome from the same single cell; cutting-edge generative AI models, proprietary wet-lab technologies, and a leading cancer biospecimen repository and molecular database identify new therapeutic candidates at accelerated speeds; and more.
Full story
-
Feb 22, 2023, 10:07 AM
by
Pharma Targeting, the bespoke research house exclusively working with pharma and biotech service providers, is celebrating its 10-year anniversary in 2023. Launched as a small custom research agency - part of The Targeting Group - the company has grown exponentially in the past decade, with global offices now across the UK, Europe, Argentina and India, and employing nearly 300 people with a backbone of world class life science experts, business strategists and marketing consultants, along with 200 PhD analysts.
Full story
-
Feb 22, 2023, 10:06 AM
by
RIM’s new Board of Directors elects Andrew Lin as the new Chairman of the Board and appoints Dr. Wen-Chyi Shyu as the new CEO
Full story
-
Feb 22, 2023, 10:05 AM
by
Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona
Specialist biometrics CRO are key sponsor and presenter at industry event to support continuous professional development in clinical data management
Full story
-
Feb 22, 2023, 01:00 AM
by
User Not Found
Bio-IT World | The gut microbiome has for the first time been linked to a causal role in endometriosis. Up to now, efforts to investigate the contributing factors have been focused primarily on genetic changes or epigenetic disorders and yet understanding of the underlying pathology remains largely a mystery.
Full story
-
Feb 21, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Funding for a proprietary AI-driven 3D structure engine for RNA drug discovery, unique binary assembly technology to deliver accurate, gene-length DNA in a benchtop instrument, a national institute that develops artificial intelligence systems to identify and assist young children with speech and language processing challenges, and more.
Full story
-
Feb 17, 2023, 10:15 AM
by
Goizueta Institute @Emory Brain Health and The Seavey Clinic Collaborating on Use of Digital Cognitive Assessments in Primary Care
Full story
-
Feb 17, 2023, 10:15 AM
by
To support greater equity in healthcare, VisualDx just partnered with the American Medical Women’s Academy (AMWA) to grant all members access to its clinical decision support tool for diagnostic and treatment decisions.
As you may know, this collaboration follows the company’s partnerships with the Gates Foundation, HHS, state of Vermont, and ACEP to enhance patient care and outcomes.
Full story
-
Feb 17, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Pharmacovigilance plays a critical role in drug safety. Pharmaceutical companies monitor newly licensed drugs, evaluate previously unreported adverse reactions, and balance drug effectiveness. We are evolving from manual pharmacovigilance to an era of precision pharmacovigilance, where a personalized approach to drug safety helps maximize the reach of new drugs and minimize adverse events.
Full story
-
Feb 16, 2023, 09:43 AM
by
14 of the top 20 pharmaceutical companies now rely on Concentriq to accelerate R&D
Full story
-
Feb 16, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Using a natural language processing program developed by Salesforce Research, scientists have engineered artificial enzymes that look and fold just like natural proteins and function just as well. The artificial intelligence tool, called ProGen, allows information from the evolutionary record of multiple protein families to generate new enzymes that could prove therapeutically useful.
Full story
-
Feb 15, 2023, 09:13 AM
by
Equiva Health, a digital patient engagement and health relationship management solution provider, is announcing its partnership with ISP provider Infiniti Mobile to launch its new ACP Connect Program.
Equiva and Infiniti Mobile are working together to create a framework to help hospitals, nursing homes, and other healthcare organizations enroll patients in the Affordable Connectivity Program (ACP), and to help these organizations engage digitally with individuals for targeted health initiatives.
Through this partnership and offering, Equiva aims to further narrow the digital divide in healthcare and improve healthcare access for at-risk populations by connecting more eligible patients with ACP’s discounted broadband service and devices—allowing those patients to take advantage of digital health solutions they haven’t previously had affordable access to.
Full story
-
Feb 14, 2023, 10:53 AM
by
Full story
-
Feb 14, 2023, 10:47 AM
by
MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, recently presented $100,000 each to Michael Leibowitz, MD, PhD from the University of Colorado Cancer Center and Dr. Daniel Regan, DVM, PhD, DACVP from the Flint Animal Cancer Center at Colorado State University, totaling $200,000 in research funds to move rare bone cancer research forward. Christina Ip-Toma, MIB Agents’ Director of Scientific Programs, presented the award to Dr. Leibowitz on February 8 and Dr. Regan on February 9.
Full story